Resources Contact Us Home
Modified leukotoxin protein

Image Number 15 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Lettuce sister lines PX06514083, PX06514153, PX06514201 and PX06514204
Methods for selective reverse mask planarization and interconnect structures formed thereby
Low latency interrupt collector
Treatment of cancer using the sodium salt of a benzoic acid derivative
System and method of creating and providing SMS http tagging
Method for production of fermentable sugars from biomass
Technology for managing traffic via dual homed connections in communication networks
  Randomly Featured Patents
Variable valve-timing engine
Contact protection circuit and high voltage relay comprising the same
2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
Method of producing a multiple-wall pipe structure with anticorrosion end protection
Sheet material dispenser
Method for predicting adhesive interactions using molecular modeling
Selective mode multi-stage vacuum pump
Prostate specific antigen oligo-epitope peptide
Carbonylation catalyst system
Method and system for performing complex sampling of signals by using two or more sampling channels and for calculating time delays between these channels